SS-31

Targets the mitochondria themselves — the cell’s power plants — to steady energy (ATP) production and tamp down the oxidative stress that builds up as they age or get damaged. People run it for energy, faster recovery, and as a longevity play, on the theory that better-functioning mitochondria pay off everywhere at once.

It’s one of the few peptides that’s genuinely organelle-targeted: it crosses the cell membrane and concentrates on the inner mitochondrial membrane rather than acting at a surface receptor. The hook the community keeps coming back to is the MOTS-c contrast — MOTS-c is a signaling peptide (it tells the cell to shift its metabolism), while SS-31 is a repair/stabilization peptide (it physically props up the membrane the energy chain sits on). Different jobs, which is why they’re run together rather than swapped.

Binds cardiolipin, a lipid found almost exclusively on the inner mitochondrial membrane that organizes the proteins of the electron-transport chain into working order. By associating with cardiolipin, SS-31 helps hold that structure together — improving electron flow and ATP output and cutting the leak of reactive oxygen species that damages the membrane in the first place. It’s a stabilizing, structural effect, not a receptor it switches on or off.

The best-characterized signal, because it comes from real trials rather than anecdote, is injection-site reactions — by far the most common, and the reason the approved label exists at all. Hypersensitivity reactions have also been reported. Beyond that the clinical safety profile reads as mild-to-moderate and generally well-tolerated. The honest gap: trial safety data covers patients dosed under supervision for defined periods, not healthy people self-running it long-term for longevity, and as with everything here the grey-market supply is unregulated — insist on a certificate of analysis.

The canonical pairing is MOTS-c — the two mitochondrial peptides run together because they do different jobs: SS-31 repairs and stabilizes the inner membrane, MOTS-c signals the metabolic shift. Neither is a substitute for the other, which is the whole reason they’re stacked rather than chosen between. Beyond that pairing there’s no established peptide protocol; the supporting work people fold in is conventional mitochondrial support (CoQ10, exercise) rather than other compounds.